Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Reich, O; Nogales, FF; Regauer, S.
Gonadotropin-releasing hormone receptor expression in endometrial stromal sarcomas: an immunohistochemical study.
Mod Pathol. 2005; 18(4):573-576
Doi: 10.1038/modpathol.3800325
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Reich Olaf
- Co-Autor*innen der Med Uni Graz
-
Regauer Sigrid
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Gonadotropin-releasing hormone and its receptors have been identified in several human malignancies. We evaluated gonadotropin-releasing hormone receptor expression in 30 primary and recurrent endometrial stromal sarcomas. Archival formalin-fixed and paraffin-embedded material was analyzed immunohistochemically with antisera to gonadotropin-releasing hormone receptor type I and gonadotropin-releasing hormone receptor type II using the peroxidase-antiperoxidase method. Gonadotropin-releasing hormone receptor types I and II were demonstrated in most primary endometrial stromal sarcomas in varying intensity and percentage (range, 10-100%). The staining pattern was either diffuse cytoplasmic or granular/vesicular in perinuclear distribution. Recurrences stained stronger than primary tumors. The demonstration of gonadotropin-releasing hormone receptors I and II expression in endometrial stromal sarcomas may be a rationale for a clinical study of gonadotropin-releasing hormone analogs in the treatment of women with endometrial stromal sarcomas.
- Find related publications in this database (using NLM MeSH Indexing)
-
Female -
-
Humans -
-
Immunohistochemistry -
-
Neoplasm Metastasis -
-
Neoplasm Recurrence, Local -
-
Receptors, LHRH - biosynthesis
-
Sarcoma, Endometrial Stromal - metabolism
- Find related publications in this database (Keywords)
-
endometrium
-
stromal sarcoma
-
GnRH
-
treatment